We publish news of technology innovations, investment opportunities, together with updates from spin-out & start-up companies and licensees
An Oxford DPhil student has discovered that treating enzymes with a bacterial superglue allows them to be boiled without loss of function.
'Nature' article mentions the £1.25m University of Oxford Isis Fund as part of a growing trend for Universities and technology commercialisation groups to increase their role in funding early research to bring discoveries to market.
Oxford University Innovation (Hong Kong) is pleased to announce the launch of a new Industry Alliance Programme which builds on success of an earlier pilot auto industry support programme.
Should a breathless child with fever be treated with antibiotics in case they have pneumonia? This is the question emergency doctors ask themselves many times a day, and currently it takes over 24 hours to get a definitive answer.
A University of Oxford spin-out, OxSyBio, will develop 3D printing techniques to produce tissue-like synthetic materials for wound healing and drug delivery.
Next generation carbon nanomaterials such as graphene, carbon nanotubes and fullerenes, with their unique physical properties, have been hailed as “miracle materials”.
Reviving a gene which is “turned down” after birth is potentially the key to treating Duchenne Muscular Dystrophy, an untreatable muscle-wasting condition which affects one in every 3,500 boys.
Oxford University Innovation (Hong Kong), a subsidiary of the technology commercialisation company of the University of Oxford, has established a pilot support programme for Australian automotive engineering companies looking for Chinese partners.
Wellcome Trust's VC arm backs an Isis spinout developing a gene therapy for inherited blindness.
Oxford University Innovation announced that OxSonics has raised £2.7 million to develop therapeutic technology which uses ultrasound devices in combination with ultrasound-sensitive nanoparticles.
